Trial reportPatient education and counseling2014
Presenting efficacy information in direct-to-consumer prescription drug advertisements.
Trial report in Patient education and counseling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.Medical decision making : an international journal of the Society for Medical Decision Making · 2019Trial
- Taking Repeated Exposure into Account: An Experimental Study of Direct-To-Consumer Prescription Drug Television Ad Effects.Journal of health communication · 2019Trial
- Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.Journal of health communication · 2017Trial
- Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.Journal of health communication · 2016Trial
- Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.Patient education and counseling · 2016Trial
- Laypersons' understanding of statistical concepts commonly used in prescription drug promotion: A review of the research literature.Research in social & administrative pharmacy : RSAP · 2024Article
- Visual images of prescription drug benefits in direct-to-consumer television advertisements.Patient education and counseling · 2021Article
- Assessing the Inclusion of Foil Items in a Scale to Measure Recognition of Health Messages.Communication methods and measures · 2021Article
- Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.Research in social & administrative pharmacy : RSAP · 2020Article
- Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.Health communication · 2019Article
- Assessing hearing and cognition challenges in consumer processing of televised risk information: Validation of self-reported measures using performance indicators.Preventive medicine reports · 2018Article
- Attention to and Distraction from Risk Information in Prescription Drug Advertising: An Eye Tracking Study.Journal of public policy & marketing : JPP&M : an annual publication of the Division of Research, Graduate School of Business Administration, the University of Michigan · 2017Article
- Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads.Journal of health communication · 2016Article
- Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.Patient education and counseling · 2016Article
- An Empirical Examination of the FDAAA-Mandated "Toll-Free Statement" for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements.Journal of public policy & marketing : JPP&M : an annual publication of the Division of Research, Graduate School of Business Administration, the University of Michigan · 2016Article
- Communicating Benefit and Risk Information in Direct-to-Consumer Print Advertisements: A Randomized Study.Therapeutic innovation & regulatory science · 2015Article
- Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.Journal of health communication · 2015Article
- The FDA's Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity.Journal of primary care & community healthArticle
- Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.Health marketing quarterlyArticle
- Scope, Methods, and Overview Findings for the Making Numbers Meaningful Evidence Review of Communicating Probabilities in Health: A Systematic Review.MDM policy & practiceReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveWe evaluated whether presenting prescription drug efficacy information in direct-to-consumer (DTC) advertising helps individuals accurately report a drug's benefits and, if so, which numerical format is most helpful.
methodsWe conducted a randomized, controlled study of individuals diagnosed with high cholesterol (n=2807) who viewed fictitious prescription drug print or television ads containing either no drug efficacy information or efficacy information in one of five numerical formats. We measured drug efficacy recall, drug perceptions and attitudes, behavioral intentions, and drug risk recall.
resultsIndividuals who viewed absolute frequency and/or percentage information more accurately reported drug efficacy than participants who viewed no efficacy information. Participants who viewed relative frequency information generally reported drug efficacy less accurately than participants who viewed other numerical formats.
conclusionAdding efficacy information to DTC ads-both in print and on television-may potentially increase an individual's knowledge of a drug's efficacy, which may improve patient-provider communication and promote more informed decisions. PRACTICE IMPLICATIONS: Providing quantitative efficacy information in a combination of formats (e.g., absolute frequency and percent) may help patients remember information and make decisions about prescription drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.